(Q33364240)

English

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma

scientific article

Statements

Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma (English)
Peter McLaughlin
Jorge E Romaguera
Frederick Hagemeister
Felipe Samaniego
Michael Wang
Kristine Broglio
Barry Samuels
Frederic Gilles
Andreas H Sarris
Elizabeth Trehu
David Schenkein
Alma M Rodriguez
21 December 2004

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit